Kratom is not a federally controlled substance. That single fact surprises many consumers, and it explains why the plant’s legal status in the United States is a patchwork: a federal position that has shifted three times in a decade, sitting underneath fifty state codes that range from outright prohibition to silence.
This article sets out the federal framework as it stands in August 2026, the categories into which state approaches fall, and the checks a consumer should make before purchasing. It does not offer a state-by-state list; those change too often for a static article to be reliable, and the reader’s own state code is the only authoritative source.
Federal status: what the Controlled Substances Act does and does not say
Mitragyna speciosa, the tree from which kratom is produced, and its principal alkaloid mitragynine do not appear in any schedule of the Controlled Substances Act. The Drug Enforcement Administration has attempted to change that once. On August 31, 2016, the agency published a notice of intent to temporarily place mitragynine and 7-hydroxymitragynine in Schedule I under the emergency scheduling provisions of 21 U.S.C. § 811(h). Six weeks later, on October 13, 2016, the DEA withdrew the notice, citing the volume of public comment and a pending scientific and medical evaluation from the Food and Drug Administration. No scheduling action against the whole leaf has followed.
The DEA instead lists kratom among its “drugs of concern,” a category for substances that are not controlled under the CSA but which the agency monitors. The FDA, for its part, has stated that kratom is not lawfully marketed as a dietary supplement or drug and has issued warning letters and import alerts against products bearing disease claims. Neither position amounts to a federal prohibition on possession or sale of leaf products.
The federal picture changed in July 2026, though not in the way earlier proposals contemplated. On July 1, 2026, the DEA announced its intent to temporarily place 7-hydroxymitragynine in Schedule I when present above a specified threshold, along with three related compounds: mitragynine pseudoindoxyl, MGM-15, and MGM-16. The notices were published in the Federal Register on July 6, 2026, under docket DEA-1570. The threshold, as described in the notice, is 0.05 percent 7-hydroxymitragynine by weight or more than 1 milligram per article. The notice states that the action does not apply to botanical kratom material containing naturally occurring 7-hydroxymitragynine below that threshold.
The distinction is deliberate. Natural kratom leaf contains 7-hydroxymitragynine only in trace amounts, well below 0.05 percent. The products the DEA is targeting are concentrated or semi-synthetic isolates sold in tablet and extract form, many of which exceed the threshold by orders of magnitude. Under § 811(h), a temporary scheduling order could not issue before August 5, 2026, and takes effect on publication. Readers should consult the Federal Register docket for the current status of the order, since this article cannot anticipate its publication date.
Three categories of state approach
With no federal scheduling of the leaf, state legislatures have set the operative rules. Their approaches fall into three groups, with a fourth layer beneath them.
Prohibition. A minority of states have added mitragynine, 7-hydroxymitragynine, or both to their own controlled substance schedules, making possession and sale offenses under state law regardless of federal status. Several of these enactments date from 2014 to 2016, before the federal withdrawal, and a small number have been added or amended since. In these states the product’s form is irrelevant; leaf, capsule, and extract are all covered.
Regulation under a consumer protection statute. A larger group has chosen to regulate rather than ban, typically through legislation styled as a Kratom Consumer Protection Act. The common elements are a minimum purchase age, labeling requirements, limits on contaminants and on 7-hydroxymitragynine content, prohibitions on adulteration with other substances, and in some states a registration requirement for processors or products. Utah enacted the first such statute in 2019, codified at Utah Code Title 4, Chapter 45.
Utah is also the clearest example of where this model is heading. In March 2026 the legislature passed S.B. 45, effective May 6, 2026, which restricts retail sale to “pure leaf kratom” as defined in the statute, prohibits the sale of extracts and extract-based products, limits sales to registered retail tobacco specialty businesses, and requires both processors and retailers to register with the Department of Agriculture and Food. The 2019 act remains in place, but its permissive framing has been narrowed considerably. Other states with consumer protection statutes have amended theirs in the same direction, chiefly by tightening alkaloid limits and adding 7-hydroxymitragynine caps.
No kratom-specific law. The remaining states, still the largest group, have no statute that names kratom. Products are sold subject to general food, supplement, and consumer protection law, with no age minimum, testing requirement, or alkaloid limit specific to the plant. Enforcement in these states tends to arise from adulteration or labeling violations under existing law rather than from the product’s identity.
Local ordinances. Beneath all three categories, some counties and municipalities have enacted their own restrictions, ranging from age limits to full local bans, in states where the product is otherwise legal. A consumer who has confirmed state law has not necessarily confirmed local law.
Why the federal threshold matters at the state level
The 0.05 percent line in the DEA’s July 2026 notice does something the 2016 proposal did not: it distinguishes leaf from concentrate by a measurable standard. Several state statutes already use alkaloid thresholds to draw the same line, and the federal figure gives legislatures a reference point that can be tested in a laboratory rather than argued over in a hearing.
The practical effect for consumers is that the legal category a product falls into will increasingly depend on its chemistry rather than its name. A powder labeled kratom that tests below the threshold and a tablet labeled kratom that tests far above it are, for scheduling purposes, different substances. Labeling has not always kept pace with that distinction.
What consumers should check
The following checks apply regardless of which state a consumer is in.
- Search the state’s controlled substance schedule for “mitragynine” and “kratom.” If either appears, the product is prohibited at the state level.
- Check whether the state has a kratom-specific consumer protection statute, and if so, what it requires as to purchase age, labeling, and product form. Some states now permit leaf only.
- Search the county and municipal code for the same terms. Local restrictions exist in otherwise permissive states.
- Confirm the purchase age. Where a statute sets one, it is usually 18 or 21; retailers in states without a statute may set their own.
- Determine whether the product is leaf or concentrate. A label that leads with a 7-hydroxymitragynine milligram figure describes an isolate product, which now sits in a different federal category from leaf.
- Confirm that the vendor discloses alkaloid content and publishes batch-specific laboratory results. The consumer who chooses to buy kratom from a vendor that tests every batch has a document to check against the state’s alkaloid and contaminant limits; the consumer who does not is relying on the label alone.
The direction of travel
The federal government has, for the first time, drawn a chemical line between the botanical leaf and concentrated derivatives, and left the leaf on the uncontrolled side of it. States that regulate rather than prohibit are converging on the same distinction, with Utah’s 2026 amendment as the leading example. States that prohibit outright have not, so far, been moved by either development.
For the consumer, the practical rule has not changed. Before purchasing, read the state code, then the local code, then the label. A purchase that is lawful in one county may be an offense twenty miles away, and no vendor’s shipping policy substitutes for that check.